Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Peringkat dalam Saham #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Harga Saham
$0.39
Kapitalisasi Pasar
$13.79M
Perubahan (1 hari)
-13.53%
Perubahan (1 tahun)
-68.80%
Negara
IL
Perdagangan NeuroSense Therapeutics Ltd. (NRSN)

Kategori

Riwayat hasil dividen untuk NeuroSense Therapeutics Ltd. (NRSN)
Hasil dividen (TTM) dari NeuroSense Therapeutics Ltd. (simbol saham: NRSN) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk NeuroSense Therapeutics Ltd. (NRSN) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE